Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
To determine the 1 year progression-free survival (PFS) of the combination of metformin and standard chemotherapy in patients with previously untreated advanced or metastatic pulmonary adenocarcinoma.
Epistemonikos ID: 1b529d6bab3c55dab3a49618801edfed41a11665
First added on: May 10, 2024